 |

Ding R, Li B, Muthukumar T, Dadhania D, Medeiros M, Hartono C, Serur D, Seshan SV, Sharma VK, Kapur S, and Suthanthiran M. CD103 mRNA levels in urinary cells predict acute rejection of renal allografts. Transplantation 75: 1307-1312, 2003. [PubMed] [Reprint]
Matthews JB, Ramos E, Bluestone JA. Clinical
trials of transplant tolerance: slow but steady progress.
Am J Transplant 3:794-803, 2003. [PubMed]
[Reprint]
Mazariegos GV, Zahorchak AF, Reyes J, Ostrowski L,
Flynn B, Zeevi A, Thomson AW. Dendritic cell
subset ratio in peripheral blood correlates with successful
withdrawal of immunosuppression in liver transplant
patients. Am J Transplant 3:689-96, 2003. [PubMed]
[Reprint]
Muthukumar T, Ding R, Dadhania D, Medeiros M, Li B, Sharma VK, Hartono C, Serur D, Seshan S, Volk H-D, Reinke P, Kapur S, and Suthanthiran M. Serine proteinase inhibitor-9, an endogenous blocker of granzyme B/perforin lytic pathway, is hyperexpressed during acute rejection of renal allografts. Transplantation 75: 1565-1570, 2003. [PubMed] [Reprint]
Nepom, G. T. MHC multimers: expanding the clinical
toolkit Clin. Immunol. 106:1-4, 2003. [PubMed]
[Reprint]
Reijonen, H. and Kwok, W. W. Use of HLA class II tetramers in tracking antigen-specific T cells and mapping T-cell epitopes. Methods 29:282-288, 2003. [PubMed] [Reprint]
Abstracts
Anantharaman P, Dadhania D, Muthukumar T, Aull M, Seshan S, Hartono C, Serur D, Ding R, Li B, Suthanthiran M, Kapur S, Noninvasive surrogate for protocol biopsies of renal allografts and a mechanistic guide for the weaning of immunosuppressive therapy. [Abstract 1158] American Transplant Congress,Washington DC, May 30 - Jun 4. Am J Transpl 3 Suppl 5: 448, 2003. [Abstract]
Anantharaman P, Dadhania D, Muthukumar T, Aull M, Seshan S, Hartono C, Serur D, Ding R, Li B, Kapur S, and Suthanthiran M. Measurement of mRNA for granzyme B in urine in the first week of renal transplantation predicts clinical as well as histological outcome. [Abstract 1129] American Transplant Congress, Washington, DC, May 30-Jun 4. Am J Transpl 3 Suppl 5: 441, 2003. [Abstract]
Creticos PS, Lighvani SS, Bieneman AP, Balcer-Whaley SP, Norman PS, Lichtenstein LM, Schroeder JY. Enhanced IL10 Secretion by PBMC During the Ragweed Season: Effects of AIC Immunotherapy vs Placebo. J. Allergy Clin. Immunol. Vol. 111, S201 (530), 2003. Presented at 60th Meeting AAAAI, Denver, CO. Mar 3-7, 2003. Abstract 530. [Abstract]
Dadhania D, Muthukumar T, Anantharaman P, Ding R, Seshan S, Li B, Aull M, Hartono C, Serur D, Kapur S, Suthanthiran M. mRNA profiles of urinary cells distinguish allograft infiltrates associated with acute rejection from infiltrates that do not cause proximate acute rejection. [Abstract 48] American Transplant Congress, Washington, DC, May 30-Jun 4.Am J Transpl 3 Suppl 5:163, 2003. [Abstract]
Fudaba Y, Shaffer JM, Kraus A, Cosimi AB, Delmonico FL, Dey B, Kawai T, McAfee S, Preffer F, Tolkoff-Rubin N, Sachs DH, Saidman SL, Spitzer TR, Sykes M. Alloresponses in tolerant recipients of combined kidney/bone marrow transplantation with non-myeloablative conditioning. [Abstract 640] American Transplant Congress, Washington, DC, May 30-June 4, 2003. [Abstract]
Lakey JRT, Ricordi C, Hering B, DiMercurio B, Lindblad R, O'Neil J, Olack B, Reems JA, Ansite J, Kirlew T, Brandhorst H, Bertuzzi F, Bucher P, Oberholzer J, Ramos E, Viviano L, Shapiro AMJ. Standardization of human islet isolation for an international multi-center transplant trial. [Abstract 571] American Transplant Congress, Washington, DC, May 30-June 4, 2003. [Abstract]
Mazariegos GV, Zahorchak A, Zeevi A, Flynn B, Logar AJ, Reyes J, Thomson A. Dendritic cell subsets in peripheral blood of patients successfully withdrawn from immunosuppression after liver transplantation (LTx). [Abstract 644] American Transplant Congress, Washington DC, May30 - Jun 4, 2003. [Abstract]
Shapiro J, Hering B, Ricordi C, Dimercurio B, Lindblad
R, Cagliero E, Brendel M, Robertson RP, Berney T, Oberholzer
J, Secchi A, Brennan D, Ramos E, Viviano L, Ryan E,
Lakey J. International multicenter trial of
islet transplantation using the Edmonton protocol in
patients with type 1 diabetes. [Abstract 3]
American Transplant Congress, Washington, DC, May 30-June
4, 2003. [Abstract] Zhu S, Hu D, Lyu SC, Wong L, Huntsman
S, Heinemeyer E, Clayberger C, Bluestone J. T
cell activation kinetics from human peripheral blood
lymphocytes (PBL) using Affymetrix GeneChip arrays.
FOCIS 2003 (Federation of Clinical Immunology Societies),
Paris, France, May 15-19, 2003. [Abstract]
Zhu S, Hu D, Wong L, Huntsman S,
Heinemeyer E, Bluestone J. Use of a low quantity
of RNA for Affymetrix GeneChip arrays. Advanced
Microarray Data Analysis, Bethesda, MD, Jan 20, 2003.
[Abstract]
Letters
Shapiro AMJ, Ricordi C, Hering B. Edmonton's islet success has indeed been replicated elsewhere. [Editorial] Lancet 362:1242, 2003. [PubMed] [Reprint]
|
 |